Home Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial
 

Keywords :   


Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial

2014-05-31 23:43:29| Logistics - Topix.net

Partial responses in patients with each of TrkA, ROS1 and ALK alterations, and in patients with each of lung cancer, colorectal cancer and neuroblastoma an oncology precision medicine biotechnology company, announced today that interim results from the first-in-human ALKA-372-001 Phase I clinical trial of RXDX-101, the company's proprietary oral ... (more)

Tags: data trial phase clinical

Category:Transportation and Logistics

Latest from this category

All news

24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
Transportation and Logistics »
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »